Abstract
The SRIs represent a major breakthrough in the treatment of OCD. Recent studies suggest that these medications are safe and effective for children and adolescents with OCD, but the SRIs are not free of side effects. Frequent side effects include heartburn, diarrhea, and behavioral activation. The long half‐life of the SRIs mandates slow upward adjustment to avoid overshooting the optimal dose. Drugs that are metabolized in the liver, such as neuroleptics, can retard the processing of the SRIs, resulting in an increased dose of both drugs. Although the SRIs often are effective in the treatment of OCD in children and adolescents, they are not effective in all cases, and other treatments such as behavioral treatment may be needed as an adjunct to pharmacotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
